TMPRSS4 and gastric cancer: Recently, the overexpression of TMPRSS4 has been shown to be associated with poor prognosis in GC patients at stages II and III post-surgery.16 However, a few studies have documented the impact of TMPRSS4 on adjuvant chemotherapy in GC patients who underwent surgery.